April 6, 2016 – MONTREAL, QUEBEC – Relevium Technologies Inc. (TSX.V – “RLV”) (Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to provide an update regarding the previously announced corporate roll-up strategy, focused on acquiring products, technologies or companies within the rapidly expanding global health and wellness sector.
In addition to undergoing initiatives to commercialize, partner and license its Patented Technology, Relevium has entered into discussions with potential acquisition targets consisting of revenue generating and profitable businesses well aligned with the Company’s strategy and market focus. Management plans to continue to provide progress updates and anticipates it will enter into exclusive discussions with some of these targets during the second quarter of this calendar year.
In addition to products and technologies for Pain, Recovery and Performance, management is also examining opportunities in the delivery of comprehensive wellness services. Management believes that the growth in the wellness sector of the economy will be fueled by Baby Boomers, which represent approximately one third of the U.S. and Canadian population. This is historically the largest¸ most active and health conscious consumer group entering pre-retirement. This consumer group seeks a balanced and active lifestyle combined with personalized care and unique product offerings, all as viable alternatives to pharmaceutical prescription drugs.
Leena Lakdawala, CEO of Relevium Technologies Inc. stated: “The global health and wellness market is projected to hit record high levels by 2017, and today’s informed consumers are choosing a balanced lifestyle focused on health and wellness. People are staying active longer and eating healthier to avoid disease and medication dependencies. Relevium’s corporate strategy aims at leveraging this growing demand by strategically defining three unique verticals of Pain Relief, Recovery and Performance and offering unique deliverables under one company”
About Relevium Technologies Inc.
Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies within the scope of the expanding health and wellness sector, specifically under three important verticals: Pain Relief, Recovery and Performance. Relevium Technologies Inc. currently holds patented intellectual property for application of static magnetic fields on direct-to-consumer devices, which aid in decreasing pain, improving recovery time and enhancing overall physical performance.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
CEO and Director
For additional information, please contact:
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the business and operations of the Company. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the ability of the Company to execute and achieve its business objectives. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. There can be no assurance that the conditions to the transactions contemplated by the potential letter of intents will be satisfied or that those transactions will be completed. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.